2006
DOI: 10.1007/s00431-006-0126-z
|View full text |Cite
|
Sign up to set email alerts
|

Acute pancreatitis after growth hormone treatment: disease or treatment linked?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…To the contrary, some clinical reports have shown that prolonged application of GH to the GH-deficient patients could be complicated, in some individuals, by the development of mild acute pancreatitis [22][23][24][25]. This complication of GH therapy was noted in 7 cases per 24,000 patients treated with GH.…”
Section: Discussionmentioning
confidence: 83%
“…To the contrary, some clinical reports have shown that prolonged application of GH to the GH-deficient patients could be complicated, in some individuals, by the development of mild acute pancreatitis [22][23][24][25]. This complication of GH therapy was noted in 7 cases per 24,000 patients treated with GH.…”
Section: Discussionmentioning
confidence: 83%
“…One study showed that the single effects of growth hormone down-regulated apoptosis of intestinal mucosa cells in acute necrotizing pancreatitis, 36 but growth hormone is seldom used on its own; some studies indicate that the excessive application of it may induce or aggravate acute pancreatitis. 37,38 In conclusion, we found that intestinal mucosa was significantly damaged, and the apoptosis of intestinal mucosa cells increased in this SAP model. The application of Saizen in combination with Stilamin could decrease the apoptosis of intestinal mucosa cells and increase intestinal mucosa barrier function, which suggested that Saizen has significant protective effects on intestinal mucosa in experimental SAP.…”
Section: Discussionmentioning
confidence: 91%
“…The exact effects of AAS [ 20 ] and growth hormone [ 21 ] on DIAP are not well understood. Predictions are that AAS can induce an immune-mediated inflammatory response, direct cellular toxicity, pancreatic ductal constriction, arteriolar thrombosis, and metabolic effects in the pancreas [ 20 ], and it is observed in pediatric studies that growth hormone causes secretion of pancreatic enzymes [ 22 ]. Animal studies have shown that arginine, which is a potent secretagog of growth hormone, causes direct damage to the pancreatic acinar cells and dose-related necrotizing pancreatitis in rats [ 15 ].…”
Section: Discussionmentioning
confidence: 99%